MenACWY Vaccine

Concepts

• vaccines
• meningococcal disease
• supply of a vaccine
• provision of a vaccine
• menacwy vaccine
• menacwy
• part of the national childhood immunisation programme.the
• period of the contract
• neisseria meningitidis groups a
• period of the optional extension

Location

United Kingdom: To a location in England to be notified to the successful bidder(s) following contract award

Description

Provision for the supply of a vaccine to protect against meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y (MenACWY)

Total Quantity or Scope

The provision of a vaccine to protect against meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y, to be used as part of the national childhood immunisation programme.The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to4.7 million doses of vaccine.Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. Additional information: Value - this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value so as not to prejudice the legitimate commercial interest of the supplier

Award Detail

Renewal Options

This contract has the option to be extended for a period or periods up to an additional 24 months

Award Criteria

CPV Codes

• 33651600 - Vaccines

Indicators

• Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The contract(s) is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.